5448-49-7,MFCD00466396
Catalog No.:AA00DCXU

5448-49-7 | 2-Chloro-n-thiazol-2-yl-acetamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95%
in stock  
$123.00   $86.00
- +
5g
95%
in stock  
$489.00   $343.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00DCXU
Chemical Name:
2-Chloro-n-thiazol-2-yl-acetamide
CAS Number:
5448-49-7
Molecular Formula:
C5H5ClN2OS
Molecular Weight:
176.6240
MDL Number:
MFCD00466396
SMILES:
ClCC(=O)Nc1nccs1
NSC Number:
17824
Properties
Properties
 
Form:
Solid  
MP:
162-164℃  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
133  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.4  

Downstream Synthesis Route

[1]EuropeanJournalofMedicinalChemistry,1992,vol.27,p.709-716

[2]MedicinalChemistryResearch,2014,vol.23,p.2780-2792

[3]Pharmazie,1987,vol.42,p.716-717

[4]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.4377-4381

[5]ACSCombinatorialScience,2017,vol.19,p.533-543

[6]Patent:WO2010/75290,2010,A1.Locationinpatent:Page/Pagecolumn43

[7]JournalofChemistry,2017,vol.2017

[8]Patent:WO2009/1021,2008,A1.Locationinpatent:Page/Pagecolumn71

[9]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.4932-4935

[10]EuropeanJournalofMedicinalChemistry,2012,vol.54,p.615-625

[11]BioorganicandMedicinalChemistry,2014,vol.22,p.5378-5391

[12]Patent:US2780631,1956,

[13]JournaloftheIndianChemicalSociety,1981,vol.58,p.171-173

[14]Molecules,2003,vol.8,p.472-479

[15]Phosphorus,SulfurandSiliconandtheRelatedElements,2004,vol.179,p.1449-1454

[16]EuropeanJournalofMedicinalChemistry,2005,vol.40,p.607-613

[17]BioorganicandMedicinalChemistry,2006,vol.14,p.4820-4833

[18]ChemistryofNaturalCompounds,2006,vol.42,p.470-472

[19]BioorganicandMedicinalChemistry,2007,vol.15,p.6763-6774

[20]IlFarmaco,2005,vol.60,p.969-973

[21]JournalofMedicinalChemistry,2008,vol.51,p.1601-1609

[22]Phosphorus,SulfurandSiliconandtheRelatedElements,2007,vol.182,p.1793-1803

[23]JournalofMedicinalChemistry,2008,vol.51,p.5221-5228

[24]BioorganicandMedicinalChemistry,2010,vol.18,p.6351-6359

[25]BioorganicandMedicinalChemistry,2011,vol.19,p.1321-1327

[26]BioorganicandMedicinalChemistry,2011,vol.19,p.7612-7622

[27]SyntheticCommunications,2012,vol.42,p.3361-3367

[28]BioorganicandMedicinalChemistry,2013,vol.21,p.532-539

[29]BioorganicandMedicinalChemistryLetters,2013,vol.23,p.2560-2565

[30]BioorganicandMedicinalChemistry,2013,vol.21,p.4332-4341

[31]MedicinalChemistryResearch,2013,vol.22,p.2293-2302

[32]MedicinalChemistryResearch,2013,vol.22,p.4110-4124

[33]EuropeanJournalofMedicinalChemistry,2013,vol.70,p.846-856

[34]EuropeanJournalofMedicinalChemistry,2014,vol.81,p.89-94

[35]Lettersindrugdesignanddiscovery,2013,vol.10,p.44-48

[36]BioorganicandMedicinalChemistry,2015,vol.23,p.4899-4910

[37]EuropeanJournalofMedicinalChemistry,2016,vol.107,p.165-179

[38]Phosphorus,SulfurandSiliconandtheRelatedElements,2016,vol.191,p.1166-1173

[39]Molecules,2018,vol.23

[40]EuropeanJournalofMedicinalChemistry,2018,vol.155,p.905-924

[41]ChemMedChem,2019,vol.14,p.1329-1335

[42]BioorganicChemistry,2020,vol.100

[43]EuropeanJournalofMedicinalChemistry,2020,vol.196

[44]EuropeanJournalofMedicinalChemistry,2020,vol.202

591-55-9    5448-49-7   
2-(Pyrimidin-5-ylamino)-N-thiazol-2-yl-acetamide 

[1]JournaloftheIndianChemicalSociety,1982,vol.59,p.1097-1099

[1]Lettersindrugdesignanddiscovery,2013,vol.10,p.44-48

[1]Lettersindrugdesignanddiscovery,2013,vol.10,p.44-48

5448-49-7    30437-09-3   
2-4-(4-phenylphthalazin-1-yl)piperazin-1-yl-N-(thiazol-2-yl)acetamide 

[1]Abou-Seri,SaharM.;Eldehna,WagdyM.;Ali,MamdouhM.;AbouElElla,DalalA.[EuropeanJournalofMedicinalChemistry,2016,vol.107,p.165-179]

Literature

Title: Regioselective synthesis and antimicrobial activities of some novel aryloxyacetic acid derivatives.

Journal: European journal of medicinal chemistry 20120401

Title: Organosilicon-containing thiazole derivatives as potential lipoxygenase inhibitors and anti-inflammatory agents.

Journal: Bioinorganic chemistry and applications 20070101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido]thio-4H-1,2,4-triazole derivatives.

Journal: European journal of medicinal chemistry 20050601

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:5448-49-7 Molecular Formula|5448-49-7 MDL|5448-49-7 SMILES|5448-49-7 2-Chloro-n-thiazol-2-yl-acetamide
Catalog No.: AA00DCXU
5448-49-7,MFCD00466396
5448-49-7 | 2-Chloro-n-thiazol-2-yl-acetamide
Pack Size: 1g
Purity: 95%
in stock
$123.00 $86.00
Pack Size: 5g
Purity: 95%
in stock
$489.00 $343.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00DCXU
Chemical Name: 2-Chloro-n-thiazol-2-yl-acetamide
CAS Number: 5448-49-7
Molecular Formula: C5H5ClN2OS
Molecular Weight: 176.6240
MDL Number: MFCD00466396
SMILES: ClCC(=O)Nc1nccs1
NSC Number: 17824
Properties
Form: Solid  
MP: 162-164℃  
Storage: Keep in dry area;2-8℃;  
Complexity: 133  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 10  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.4  
Downstream Synthesis Route
96-50-4    79-04-9    5448-49-7 

[1]EuropeanJournalofMedicinalChemistry,1992,vol.27,p.709-716

[2]MedicinalChemistryResearch,2014,vol.23,p.2780-2792

[3]Pharmazie,1987,vol.42,p.716-717

[4]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.4377-4381

[5]ACSCombinatorialScience,2017,vol.19,p.533-543

[6]Patent:WO2010/75290,2010,A1.Locationinpatent:Page/Pagecolumn43

[7]JournalofChemistry,2017,vol.2017

[8]Patent:WO2009/1021,2008,A1.Locationinpatent:Page/Pagecolumn71

[9]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.4932-4935

[10]EuropeanJournalofMedicinalChemistry,2012,vol.54,p.615-625

[11]BioorganicandMedicinalChemistry,2014,vol.22,p.5378-5391

[12]Patent:US2780631,1956,

[13]JournaloftheIndianChemicalSociety,1981,vol.58,p.171-173

[14]Molecules,2003,vol.8,p.472-479

[15]Phosphorus,SulfurandSiliconandtheRelatedElements,2004,vol.179,p.1449-1454

[16]EuropeanJournalofMedicinalChemistry,2005,vol.40,p.607-613

[17]BioorganicandMedicinalChemistry,2006,vol.14,p.4820-4833

[18]ChemistryofNaturalCompounds,2006,vol.42,p.470-472

[19]BioorganicandMedicinalChemistry,2007,vol.15,p.6763-6774

[20]IlFarmaco,2005,vol.60,p.969-973

[21]JournalofMedicinalChemistry,2008,vol.51,p.1601-1609

[22]Phosphorus,SulfurandSiliconandtheRelatedElements,2007,vol.182,p.1793-1803

[23]JournalofMedicinalChemistry,2008,vol.51,p.5221-5228

[24]BioorganicandMedicinalChemistry,2010,vol.18,p.6351-6359

[25]BioorganicandMedicinalChemistry,2011,vol.19,p.1321-1327

[26]BioorganicandMedicinalChemistry,2011,vol.19,p.7612-7622

[27]SyntheticCommunications,2012,vol.42,p.3361-3367

[28]BioorganicandMedicinalChemistry,2013,vol.21,p.532-539

[29]BioorganicandMedicinalChemistryLetters,2013,vol.23,p.2560-2565

[30]BioorganicandMedicinalChemistry,2013,vol.21,p.4332-4341

[31]MedicinalChemistryResearch,2013,vol.22,p.2293-2302

[32]MedicinalChemistryResearch,2013,vol.22,p.4110-4124

[33]EuropeanJournalofMedicinalChemistry,2013,vol.70,p.846-856

[34]EuropeanJournalofMedicinalChemistry,2014,vol.81,p.89-94

[35]Lettersindrugdesignanddiscovery,2013,vol.10,p.44-48

[36]BioorganicandMedicinalChemistry,2015,vol.23,p.4899-4910

[37]EuropeanJournalofMedicinalChemistry,2016,vol.107,p.165-179

[38]Phosphorus,SulfurandSiliconandtheRelatedElements,2016,vol.191,p.1166-1173

[39]Molecules,2018,vol.23

[40]EuropeanJournalofMedicinalChemistry,2018,vol.155,p.905-924

[41]ChemMedChem,2019,vol.14,p.1329-1335

[42]BioorganicChemistry,2020,vol.100

[43]EuropeanJournalofMedicinalChemistry,2020,vol.196

[44]EuropeanJournalofMedicinalChemistry,2020,vol.202

591-55-9    5448-49-7   
2-(Pyrimidin-5-ylamino)-N-thiazol-2-yl-acetamide 

[1]JournaloftheIndianChemicalSociety,1982,vol.59,p.1097-1099

35794-11-7    5448-49-7    900687-31-2 

[1]Lettersindrugdesignanddiscovery,2013,vol.10,p.44-48

5448-49-7    504-03-0    900658-41-5 

[1]Lettersindrugdesignanddiscovery,2013,vol.10,p.44-48

5448-49-7    30437-09-3   
2-4-(4-phenylphthalazin-1-yl)piperazin-1-yl-N-(thiazol-2-yl)acetamide 

[1]Abou-Seri,SaharM.;Eldehna,WagdyM.;Ali,MamdouhM.;AbouElElla,DalalA.[EuropeanJournalofMedicinalChemistry,2016,vol.107,p.165-179]

Literature fold

Title: Regioselective synthesis and antimicrobial activities of some novel aryloxyacetic acid derivatives.

Journal: European journal of medicinal chemistry20120401

Title: Organosilicon-containing thiazole derivatives as potential lipoxygenase inhibitors and anti-inflammatory agents.

Journal: Bioinorganic chemistry and applications20070101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido]thio-4H-1,2,4-triazole derivatives.

Journal: European journal of medicinal chemistry20050601

Building Blocks More >
518357-38-5
518357-38-5
3-Ethyl-1h-pyrazole-5-carbaldehyde
AA00DD1S | MFCD10697813
476660-41-0
476660-41-0
2-Carboxy-5-chloro-4-nitrotoluene
AA00DD63 | MFCD18071079
54208-72-9
54208-72-9
Salbutamol Acetonide
AA00DDAP | MFCD30720068
474-73-7
474-73-7
24-Hydroxycholesterol
AA00DDHH | MFCD03695560
456-88-2
456-88-2
H-DL-Phe(3-F)-OH
AA00DDPW | MFCD00004273
5198-86-7
5198-86-7
2-Bromothiazole-4-methanol
AA00DDWA | MFCD04115727
4939-28-0
4939-28-0
(2-Methyl-quinolin-4-yl)-methanol
AA00DE1P | MFCD07371472
56124-62-0
56124-62-0
Valrubicin
AA00DE8P | MFCD01939322
50592-31-9
50592-31-9
4-BROMOFLUOROBENZENE-D4
AA00DEF8 | MFCD01861659
55508-42-4
55508-42-4
Neurotensin (cattle)
AA00DELY | MFCD00076678
Submit
© 2017 AA BLOCKS, INC. All rights reserved.